We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Merck and Co Inc | NYSE:MRK | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -0.88 | -0.68% | 127.92 | 129.76 | 127.985 | 129.76 | 7,446,078 | 01:00:00 |
From May 2019 to May 2024
By Stephen Nakrosis
Merck Animal Health said Thursday the U.S. Food and Drug Administration gave approval for its Bravecto one-month chews for dogs and puppies 8 weeks and older.
The company said its Bravecto, or fluralaner, chews are "administered as a single, monthly flavored chew formulation for treatment and prevention of fleas and treatment and control of ticks."
The company also said pet owners can transition their dogs to its extended duration Bravecto products at 6 months of age, "helping to ensure consistent treatment and compliance."
Merck Animal Health, which is known as MSD Animal Health outside the U.S. and Canada, is a division of Merck & Co., Inc.
--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
July 09, 2020 17:25 ET (21:25 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year Merck Chart |
1 Month Merck Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
